Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotechnological applications for surface-engineered bacteria.

Henrik Wernérus1, Stefan Ståhl

  • 1Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology, SE-106 91 Stockholm, Sweden.

Biotechnology and Applied Biochemistry
|March 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade.

Cellular and molecular life sciences : CMLS·2026
Same author

Combining bacterial display and protein language models to engineer a CD69-binding affibody for molecular imaging of immune activation.

Protein engineering, design & selection : PEDS·2026
Same author

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Journal of biological engineering·2026
Same author

Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.

Protein engineering, design & selection : PEDS·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents.

ACS pharmacology & translational science·2025
Same journal

Development and Validation of an ELISA Method for Quantification of HuB01 in Fermentation Products.

Biotechnology and applied biochemistry·2026
Same journal

Optimization and Characterization of Poly-γ-Glutamic Acid Production From a Locally Isolated Bacillus cereus ARM24.

Biotechnology and applied biochemistry·2026
Same journal

Isolation and Characterization of a Novel Microbacterium takaoensis Lipase for Nutritional and Textural Improvement of Pizza Dough.

Biotechnology and applied biochemistry·2026
Same journal

Targeting Amastigote and Trypomastigote Phases: Multi-Epitope Vaccine Strategy Against Trypanosoma cruzi.

Biotechnology and applied biochemistry·2026
Same journal

Novel Inhibitors Targeting Class B1 Metallo-β-Lactamases in Carbapenem-Resistant Acinetobacter baumannii.

Biotechnology and applied biochemistry·2026
Same journal

Formulation of PLA/Chitosan Copolymeric Nanocarriers Enhanced the Sustained and Targeted Drug Delivery of Cinnamic Acid: In Vitro Drug Optimization and In Vivo Biodistribution in Rat Model.

Biotechnology and applied biochemistry·2026
See all related articles

Bacterial display technology uses recombinant DNA to present foreign proteins on microbial surfaces. This review covers systems for applications in vaccines, biocatalysis, diagnostics, and biosensing.

Area of Science:

  • Microbiology
  • Biotechnology
  • Vaccinology

Background:

  • Recombinant DNA technology enables heterologous protein display on microbial surfaces.
  • Both Gram-negative and Gram-positive bacteria are explored for display systems.
  • Bacterial display is a growing strategy in microbiology, biotechnology, and vaccinology.

Purpose of the Study:

  • To review common bacterial display systems and their biotechnology applications.
  • To discuss current uses and future trends in bacterial display technologies.
  • To highlight specific systems like Staphylococcus carnosus for Gram-positive display.

Main Methods:

  • Surface display of foreign antigens for vaccine development.
  • Immobilization of heterologous enzymes for biocatalysis.

Related Experiment Videos

  • Display of binding proteins (e.g., single-chain antibodies) for diagnostics and biosensors.
  • Engineering bacteria for metal ion binding and biosorption.
  • Utilizing polypeptide libraries for in vitro selection.

    • Main Results:

    • Development of 'second-generation' vaccine vectors with mucosal targeting signals.
    • Creation of engineered bacteria as whole-cell biocatalysts and diagnostic devices.
    • Exploration of recombinant bacteria as biosorbents for environmental applications.
    • Demonstration of Staphylococcus carnosus as a promising Gram-positive display system.

    Conclusions:

    • Bacterial display offers versatile platforms for diverse biotechnological applications.
    • Ongoing research focuses on enhancing immune responses and creating novel biosensors.
    • The technology holds significant potential for future advancements in medicine, industry, and environmental science.